The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 1/Signature 1
From BugSigDB
< The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies | The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 1(Redirected from The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 1/Signature 1)
Reviewed Marked as Reviewed by Svetlana up on 2025-1-31
Source: Figure 2B
Description: Volcano plots representing abundance differences (fold change) of different taxa between HC and PD patients at t = 0, t = 6, and t = 12 months. Statistically significant [–log(p) > 3; fold change > ± 1.3] compositional differences at the family levels (represented by red dots) were apparent and indicative of a PD-related GM composition.
Abundance in Group 1: increased abundance in Parkinson's disease (PD) patients at t=0 to t=12
| NCBI | Quality Control | Links |
|---|---|---|
| Lactobacillaceae |
Revision editor(s): Bolanle, Fiddyhamma, WikiWorks
